You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

Litigation Details for STATE OF WISCONSIN v. INDIVIOR INC. (E.D. Pa. 2016)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in STATE OF WISCONSIN v. INDIVIOR INC.
The small molecule drugs covered by the patents cited in this case are ⤷  Try a Trial , ⤷  Try a Trial , ⤷  Try a Trial , and ⤷  Try a Trial .

Details for STATE OF WISCONSIN v. INDIVIOR INC. (E.D. Pa. 2016)

Date Filed Document No. Description Snippet Link To Document
2017-09-08 204 2008, MonoSol applied for a patent, which was issued as patent number 8,017,150 entitled “Polyethylene Oxide-Based…subject to any patent protection. (Id.) In 1994, and in lieu of exclusivity through patent protection, … (Id. ¶ 51.) Indivior listed the ‘150 patent, as well as patent numbers 8,475,8325 and 8,603,514 in the…in July 2013 to avoid the end of patent exclusivity, or the “patent cliff.” Id. at 647–48. …reformulation was not an attempt to avoid a “patent cliff”—the end of patent exclusivity corresponding to the brand External link to document
2017-09-28 210 that MonoSol applied for patent 8,017,150, and that FDA listed this patent in the “Orange Book.” … not claim that this product was protected by patents covering the two active ingredients. As to the …Indivior admits that FDA listed the three specified patents in the Orange Book. As to the allegations regarding External link to document
2017-10-30 219 2008, MonoSol applied for a patent, which was issued as patent number 8,017,150 entitled “Polyethylene Oxide-Based…subject to any patent protection. (Id.) In 1994, and in lieu of exclusivity through patent protection, the… (Id. ¶ 51.) Indivior listed the ‘150 patent, as well as patent numbers 8,475,832 and 8,603,514 in the…the patent”). In all of these cases, the alleged antitrust conduct involved the use of the patent by …allowing companies to avoid the patent claim, extend the patent life cycle for products, and External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.